Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 19

    1.

    Comparable analysis of outcomes for allogeneic peripheral blood stem cell transplantation from matched related and matched unrelated donors in acute myeloid leukemia.

    Lee SJ, Kang BW, Moon JH, Chae YS, Kim JG, Jung JS, Cho GJ, Jo DY, Kim YK, Kim HJ, Ryoo HM, Eom HS, Lee SM, Joo YD, Won JH, Park MR, Kim MK, Hyun MS, Sohn SK.

    Acta Haematol. 2012;127(2):81-9. Epub 2011 Dec 6. Erratum in: Acta Haematol. 2012;127(2):89. Le, Sang Min [corrected to Lee, Sang Min].

    PMID:
    22143083
    [PubMed - indexed for MEDLINE]
    2.

    Phagocytosis by macrophages and endothelial cells inhibits procoagulant and fibrinolytic activity of acute promyelocytic leukemia cells.

    Xie R, Gao C, Li W, Zhu J, Novakovic V, Wang J, Ma R, Zhou J, Gilbert GE, Shi J.

    Blood. 2012 Mar 8;119(10):2325-34. Epub 2011 Dec 2.

    PMID:
    22138513
    [PubMed - indexed for MEDLINE]
    3.

    CBL mutation in chronic myelomonocytic leukemia secondary to familial platelet disorder with propensity to develop acute myeloid leukemia (FPD/AML).

    Shiba N, Hasegawa D, Park MJ, Murata C, Sato-Otsubo A, Ogawa C, Manabe A, Arakawa H, Ogawa S, Hayashi Y.

    Blood. 2012 Mar 15;119(11):2612-4. Epub 2011 Dec 2.

    PMID:
    22138511
    [PubMed - indexed for MEDLINE]
    4.

    Inhibition of the NADPH oxidase regulates heme oxygenase 1 expression in chronic myeloid leukemia.

    Singh MM, Irwin ME, Gao Y, Ban K, Shi P, Arlinghaus RB, Amin HM, Chandra J.

    Cancer. 2011 Dec 2. doi: 10.1002/cncr.26621. [Epub ahead of print]

    PMID:
    22139798
    [PubMed - as supplied by publisher]
    5.

    The prognostic difference of monoallelic versus biallelic deletion of 13q in chronic lymphocytic leukemia.

    Garg R, Wierda W, Ferrajoli A, Abruzzo L, Pierce S, Lerner S, Keating M, O'Brien S.

    Cancer. 2011 Dec 2. doi: 10.1002/cncr.26593. [Epub ahead of print]

    PMID:
    22139735
    [PubMed - as supplied by publisher]
    6.

    Influence of H2-receptor antagonists and proton pump inhibitors on dasatinib pharmacokinetics in Japanese leukemia patients.

    Takahashi N, Miura M, Niioka T, Sawada K.

    Cancer Chemother Pharmacol. 2012 Apr;69(4):999-1004. Epub 2011 Dec 7.

    PMID:
    22147077
    [PubMed - in process]
    7.

    Targeting Bcl-2 family proteins in adult T-cell leukemia/lymphoma: in vitro and in vivo effects of the novel Bcl-2 family inhibitor ABT-737.

    Ishitsuka K, Kunami N, Katsuya H, Nogami R, Ishikawa C, Yotsumoto F, Tanji H, Mori N, Takeshita M, Miyamoto S, Tamura K.

    Cancer Lett. 2012 Apr 28;317(2):218-25. Epub 2011 Dec 2.

    PMID:
    22138435
    [PubMed - indexed for MEDLINE]
    8.

    4-1BB ligand modulates direct and Rituximab-induced NK-cell reactivity in chronic lymphocytic leukemia.

    Buechele C, Baessler T, Schmiedel BJ, Schumacher CE, Grosse-Hovest L, Rittig K, Salih HR.

    Eur J Immunol. 2012 Mar;42(3):737-48. doi: 10.1002/eji.201141920. Epub 2011 Dec 20.

    PMID:
    22144129
    [PubMed - in process]
    9.

    Weekend delay in initiation of chemotherapy for acute lymphoblastic leukemia: does it matter?

    Wahl SK, Gildengorin G, Feusner J.

    J Pediatr Hematol Oncol. 2012 Jan;34(1):e8-e11.

    PMID:
    22146528
    [PubMed - indexed for MEDLINE]
    10.

    Infectious complications in adult acute myeloid leukemia: analysis of the Acute Leukemia French Association-9802 prospective multicenter clinical trial.

    Cannas G, Pautas C, Raffoux E, Quesnel B, Botton Sd, Revel Td, Reman O, Gardin C, Elhamri M, Boissel N, Fenaux P, Michallet M, Castaigne S, Dombret H, Thomas X.

    Leuk Lymphoma. 2012 Jun;53(6):1068-76. Epub 2012 Jan 31.

    PMID:
    22145959
    [PubMed - in process]
    11.

    MicroRNA-223 expression is uniformly down-regulated in B cell lymphoproliferative disorders and is associated with poor survival in patients with chronic lymphocytic leukemia.

    Zhou K, Yi S, Yu Z, Li Z, Wang Y, Zou D, Qi J, Zhao Y, Qiu L.

    Leuk Lymphoma. 2012 Jun;53(6):1155-61. Epub 2012 Jan 31.

    PMID:
    22145958
    [PubMed - in process]
    12.

    Osteolytic bone lesions in non-transformed chronic lymphocytic leukemia are not as rare as suggested.

    Seymour JF.

    Leuk Lymphoma. 2012 May;53(5):1011; author reply 1012. Epub 2012 Jan 31. No abstract available.

    PMID:
    22145957
    [PubMed - in process]
    13.

    Systemic mastocytosis is uncommon in KIT D816V mutation positive core-binding factor acute myeloid leukemia.

    Kristensen T, Preiss B, Broesby-Olsen S, Vestergaard H, Friis L, Møller MB.

    Leuk Lymphoma. 2012 Jan 31. [Epub ahead of print]

    PMID:
    22145956
    [PubMed - as supplied by publisher]
    14.

    AKT1 induces caspase-mediated cleavage of the CDK inhibitor p27Kip1 during cell cycle progression in leukemia cells transformed by FLT3-ITD.

    Yang X, Liu S, Kharbanda S, Stone RM.

    Leuk Res. 2012 Feb;36(2):205-11. Epub 2011 Dec 3.

    PMID:
    22142798
    [PubMed - indexed for MEDLINE]
    15.

    Synergistic activity of rapamycin and dexamethasone in vitro and in vivo in acute lymphoblastic leukemia via cell-cycle arrest and apoptosis.

    Zhang C, Ryu YK, Chen TZ, Hall CP, Webster DR, Kang MH.

    Leuk Res. 2012 Mar;36(3):342-9. Epub 2011 Dec 3.

    PMID:
    22137317
    [PubMed - indexed for MEDLINE]
    16.

    Clinical profile and outcome of patients of acute myeloid leukemia with high hyperdiploidy.

    Sharma SK, Sharma M, Seth T, Mishra P, Chowdhry M, Mahapatra M, Saxena R.

    Leuk Res. 2012 Mar;36(3):e60-1. Epub 2011 Dec 3. No abstract available.

    PMID:
    22137316
    [PubMed - indexed for MEDLINE]
    17.

    Epigenetic regulation of miRNA genes in acute leukemia.

    Agirre X, Martínez-Climent JÁ, Odero MD, Prósper F.

    Leukemia. 2012 Mar;26(3):395-403. doi: 10.1038/leu.2011.344. Epub 2011 Dec 6. Review.

    PMID:
    22143672
    [PubMed - indexed for MEDLINE]
    18.

    The dual mTORC1 and mTORC2 inhibitor AZD8055 has anti-tumor activity in acute myeloid leukemia.

    Willems L, Chapuis N, Puissant A, Maciel TT, Green AS, Jacque N, Vignon C, Park S, Guichard S, Herault O, Fricot A, Hermine O, Moura IC, Auberger P, Ifrah N, Dreyfus F, Bonnet D, Lacombe C, Mayeux P, Bouscary D, Tamburini J.

    Leukemia. 2011 Dec 6. doi: 10.1038/leu.2011.339. [Epub ahead of print]

    PMID:
    22143671
    [PubMed - as supplied by publisher]
    19.

    The transcriptional coactivators megakaryoblastic leukemia 1/2 mediate the effects of loss of the tumor suppressor deleted in liver cancer 1.

    Muehlich S, Hampl V, Khalid S, Singer S, Frank N, Breuhahn K, Gudermann T, Prywes R.

    Oncogene. 2011 Dec 5. doi: 10.1038/onc.2011.560. [Epub ahead of print]

    PMID:
    22139079
    [PubMed - as supplied by publisher]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk